BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.07 Cr | ₹118 Cr | ₹-7.49 Cr | ₹-2.47 Cr | ₹-0.97 Cr |
What is the latest Cash Flow from Financing Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-8.07 Cr |
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹-7.49 Cr |
| Mar2023 | ₹-2.47 Cr |
| Mar2022 | ₹-0.97 Cr |
How is Cash Flow from Financing Activities of BETA DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-8.07 Cr | Negative | |
| Mar2025 | ₹118 Cr | Positive | |
| Mar2024 | ₹-7.49 Cr | Negative | |
| Mar2023 | ₹-2.47 Cr | Negative | |
| Mar2022 | ₹-0.97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,989.7 Cr | -4.2% | 0.5% | 8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -4.2% |
0.5% |
8.3% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses